Manipal Health Enterprises came to market through an IPO that opened on 29 July 2026 and closed on 31 July 2026, and the shares listed on 5 August 2026 on BSE, NSE. The price band was ₹560 to ₹590 per share and one lot was 25 shares, so the minimum application was ₹14,750. The issue size was ₹9275.21 crore. It combined a fresh issue of new shares with an offer for sale by existing shareholders.
It listed at ₹652, a gain of 10.5% against the issue price of ₹590. Kfin Technologies Limited was the registrar to the issue, and Kotak Mahindra Capital Co.Ltd., Axis Capital Ltd., Goldman Sachs (India) Securities Pvt.Ltd., Jefferies India Pvt.Ltd., JP Morgan India Pvt.Ltd., UBS Securities India Pvt.Ltd., DBS Bank India Ltd were the lead managers.
As of 31 July 2026.
| Day |
|---|
| 1 |
| 2 |
| 3 |
Overall the issue was subscribed 5.12 times.
Manipal Health Enterprises Limited is a service provider in the field of healthcare and runs a large chain of multi-specialty hospitals, clinics, and diagnostic centers all over the country. It is a constituent of the Manipal Group which was established by T. M. A. Pai. It provides diversified healthcare facilities that include tertiary and quaternary care, organ transplant, oncology, cardiology, neurology, orthopaedics, and preventive healthcare services.
The hospitals maintained by it are well equipped with high-quality medical equipment and have expert medical practitioners working there. Manipal Health aims at providing quality and patient-oriented care along with the expansion of its presence in the healthcare market through strategic acquisitions, partnerships, and investment in its medical and digital health infrastructure.
As per September 30, 2025, the company had 38 hospitals (48 hospitals on a pro forma basis) with 10,761 licensed beds (12,367 licensed beds on a pro forma basis). They are running 17 clinics as on September 30, 2025.
As described in the offer document.
| Metric | 31-Mar-26 | 31-Mar-25 | 31-Mar-24 |
|---|
Manipal Health Enterprises Limited finalised its anchor investor allocation on July 28, 2026, raising ₹4,167.10 crore from 133 institutional investors at an anchor price of ₹590 per share. The anchor book comprises 7,06,28,768 equity shares allocated across domestic mutual funds, life insurance companies, NPS pension funds, and foreign portfolio investors.
Domestic mutual funds received 40.01% of the anchor allocation through 21 fund houses across 55 schemes, including ICICI Prudential Mutual Fund, Kotak Mutual Fund, Aditya Birla Sun Life Mutual Fund, Mirae Asset, Motilal Oswal, UTI Mutual Fund, Whiteoak Capital, Axis Mutual Fund, HSBC Mutual Fund, Tata Mutual Fund, Bandhan, Invesco India, Franklin India, Sundaram, DSP, Baroda BNP Paribas, Edelweiss, JM Financial, Mahindra Manulife, Union, and PGIM India Mutual Fund.
Notable foreign institutional participants include Nomura India Investment Fund Mother Fund at 3.83%, DSP Healthcare Fund at 2.63%, Abu Dhabi Investment Authority (two funds), Government Pension Fund Global, Polar Capital Healthcare Opportunities Fund, Public Sector Pension Investment Board, Carmignac Portfolio, Fidelity (multiple funds), Franklin Templeton (multiple funds), Prazim Trading and Investment Co., SBI Life Insurance, HDFC Life Insurance, ICICI Prudential Life Insurance, and LSOI SPV funds.
Dr.Ranjan Ramdas Pai, Manipal Global Health Services, Memg International Ltd, Kangto Investments Pte.Ltd., Imperius Healthcare Investments Pte.Ltd, Kabru Investments Pte.Ltd.. Promoter holding 81.43% before the issue and 72.08% after.
Work out the listing gain for this IPO
If the retail portion is not fully subscribed, every valid application is allotted in full. If it is oversubscribed, SEBI's rules require that as many applicants as possible receive at least one lot, so the shares are allotted by a computerised lottery across all valid applications, one lot each, until the retail portion is exhausted. Applying for more lots does not improve your chance in a lottery; it only increases what you receive if the issue is under-subscribed.
The basis of allotment document, published by the registrar on the allotment date, states the ratio: for example, one applicant in seven received one lot.
Allotment status is published by the registrar on its website, searchable by PAN, application number or demat account, and also on the exchange's website. Allotted shares are credited to the demat account the day before listing, and blocked money for unsuccessful applications is released the same day. The Rupix app can check allotment status by PAN once the registrar publishes it.
Shares list within three working days of the issue closing. On listing day the exchanges run a special pre-open session from nine o'clock, during which orders are collected and an opening price is discovered from them; trading in the share begins after that, usually around ten. The opening price is the listing price that appears on this page once the issue has listed, and the listing gain or loss is the difference between it and the issue price.
For a mainboard issue, the share then trades in the normal way with the exchange's price band for a new listing. For an SME issue, shares trade in lots rather than one at a time, and the market can be thin, so selling on listing day is not always possible at the opening price. Capital gains on shares sold within a year of allotment are short-term and taxed at the short-term rate.
Manipal Health Enterprises IPO was a ₹9,275.21 crore book-built issue, comprising a fresh issue of ₹8,000 crore and an offer for sale of ₹1,275.21 crore. It was priced at ₹560–₹590 per share with a lot size of 25 shares (₹14,750). The IPO was open from July 29 to July 31, 2026 and was subscribed 5.12x. Shares listed on BSE and NSE on August 5, 2026 at ₹652, a 10.5% premium to the issue price of ₹590.
Kfin Technologies Limited is the registrar. Kotak Mahindra Capital Co.Ltd. and 6 other book running lead managers manage the issue.
The price band of Manipal Health Enterprises IPO is ₹560 to ₹590 per share.
The lot size of Manipal Health Enterprises IPO is 25 shares.
The minimum investment for Manipal Health Enterprises IPO is approximately ₹14,750 based on the upper price band.
The allotment date of Manipal Health Enterprises IPO is Aug 3, 2026.
No GMP quote could be verified as recorded before Manipal Health Enterprises IPO listed. A grey-market observation of ₹3 per share was recorded on 5 Aug 2026, 7:15 AM IST, but without a verified listing timestamp it is not treated as the final pre-listing GMP. The shares listed at ₹652. GMP is unofficial and does not forecast or guarantee the actual listing price.
Manipal Health Enterprises IPO listed on Aug 5, 2026. It was issued at ₹652.0(NSE) and is currently around ₹653.00 as on 2-Nov-2026 3:30 PM, which is approximately 10.7% versus issue price. The 52-week high is ₹815.00.
You can check Manipal Health Enterprises IPO allotment status on the registrar or stock exchange websites using your PAN or application number after allotment. You can also check the Manipal Health Enterprises IPO allotment status on Rupix for quick and easy access.
₹560 to ₹590 per share, against a face value of ₹2. Most applicants bid at the cut-off price, the top of the band, so that the application was valid whatever price the issuer finally fixed.
One lot was 25 shares, and every application had to be a whole number of lots. At the top of the band that made the minimum application ₹14,750.
₹14,750, for one lot of 25 shares at the top of the price band. The amount was blocked in the applicant's bank account through ASBA or a UPI mandate while the issue was open, and released on the allotment date to applicants who were not allotted shares.
It opened on 29 July 2026 and closed on 31 July 2026.
The basis of allotment was published on 3 August 2026 by Kfin Technologies Limited, and allotted shares were credited to demat accounts before listing.
The shares listed on 5 August 2026 on BSE, NSE, opening at ₹652.
The issue size was ₹9275.21 crore. The fresh issue was 13,55,93,220 shares (aggregating up to ₹8000 crore). The offer for sale was 2,16,13,834 shares (aggregating up to ₹1275.21 crore).
It listed at ₹652 against an issue price of ₹590, a gain of 10.5 percent on listing day.